“Distribution of SALT Scores with Ritlecitinib Treatment up to 24 months from the ALLEGRO Phase 2b/3 and Long-Term Phase 3 Clinical Studies in Alopecia Areata”, J of Skin, vol. 8, no. 6, p. s465, Nov. 2024, doi: 10.25251/skin.8.supp.465.